作者: Yasushi Shiratori
DOI: 10.1007/978-4-431-53977-3_21
关键词:
摘要: With an accumulated evidence of natural course patients with hepatitis C virus (HCV) infection, HCV infected died from liver-related disease such as liver cirrhosis/liver failure, or hepatocellular carcinoma. Based on these findings, beneficial effect antiviral therapy for is linked to inhibition HCC development. Because the difference progression speed and fibrotic stage may affect risk development efficacy depends load, genotype host factors (age, gender, stage), benefit differ according step infection. In spite improvement treatment efficacy, still unsatisfactory, but recent studies revealed that retardation could be observed after therapy. Thus, should performed standpoint